Jeremy Kratz

7PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersChemotherapyGenome structure and regulationCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2026
Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma.

|May 27, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.

|Feb 13, 2026
Epigenetic Regulation of Higher-Order Chromatin Structure (HOCS) and Its Implication in Human Diseases.

Luisa Ladel, Bethsebie Sailo, Paromita Das

|Feb 11, 2026
Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer.

Dustin A Deming, Sean G Kraus, Joshua Brand

|Sep 08, 2025
Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.

Amani Gillette, Shirsa Udgata, Alexa E Schmitz

|Jun 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.

Geoffrey Ku, Lin Shen, Farshid Dayyani

Pageof 2

Frequent Collaborators

2 joint publications

Noelle K Loconte

2 joint publications

Shirsa Udgata

2 joint publications

Dustin A Deming

2 joint publications

Melissa C Skala